Ban on “social egg freezing” declared unconstitutional
2026年4月1日
Christopher specialises in advising on regulatory, data and commercial matters within the IT, public administrative sector, telecommunications, Life Sciences and Healthcare and in particular in the gambling / gaming industry.
He has experience working on a range of matters that include commercial market entries, resolving contractual and regulatory issues and risk minimizations, leading and undertaking practice area related corporate due diligence and responding to regulatory questions.
最新新闻和观点
International Life Sciences Newsletter - Life Sciences Legal Lens Vol 1
点击此处了解更多
AI Act and Digital Omnibus Integration of AI and health data 2026
A European Perspective #1 | 2026 will be an integration year for AI in the healthcare sector. The AI Act will enter its implementation phase, while the Digital Omnibus introduces targeted simplifications. For life sciences companies, this means structurally aligning AI governance, data protection and product regulation.
2026年3月31日
Briefing
3 / 9 观点
Global Data Hub - EU case digest
点击此处了解更多
The European Health Data Space and the GDPR: striking the balance between innovation and rights
Christopher Bakier looks at the EHDS and its interplay with the GDPR.
2025年10月13日
6 / 7 观点
